509
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Who receives naloxone from emergency medical services? Characteristics of calls and recent trends

, BAORCID Icon, , PhDORCID Icon & , MD, PhDORCID Icon

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Randa Abdelal, A. Raja Banerjee, Suzanne Carlberg-Racich, Christopher Cebollero, Neyla Darwaza, Chong Kim, Diane Ito & Josh Epstein. (2022) Real-world study of multiple naloxone administrations for opioid overdose reversal among emergency medical service providers. Substance Abuse 43:1, pages 1075-1084.
Read now
Randa Abdelal, A. Raja Banerjee, Suzanne Carlberg-Racich, Neyla Darwaza, Diane Ito & Josh Epstein. (2022) The need for multiple naloxone administrations for opioid overdose reversals: A review of the literature. Substance Abuse 43:1, pages 774-784.
Read now
Namkee G. Choi, Bryan Y. Choi, Diana M. DiNitto, C. Nathan Marti & S. David Baker. (2022) Naloxone therapy for prescription and illicit opioid poisoning cases aged 50 + in the national poison data system, 2015–2020. Clinical Toxicology 60:4, pages 499-506.
Read now
Peter C. Treitler, Kristen Gilmore Powell, Cory M. Morton, N. Andrew Peterson, Donald Hallcom & Suzanne Borys. (2022) Locational and Contextual Attributes of Opioid Overdoses in New Jersey. Journal of Social Work Practice in the Addictions 22:2, pages 108-119.
Read now

Articles from other publishers (10)

Leanne M. Confer, Danielle Kuhl & John H. Boman. (2023) The Influence of Community Disadvantage and Opioid Pill Prescriptions on Overdose Deaths in American Counties. American Journal of Criminal Justice.
Crossref
Randa Abdelal, A. Raja Banerjee, Suzanne Carlberg-Racich, Neyla Darwaza, Diane Ito, Jessica Shoaff & Josh Epstein. (2022) Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders. Harm Reduction Journal 19:1.
Crossref
Louisa M. Holmes, Andrea Rishworth & Brian H. King. (2022) Disparities in opioid overdose survival and naloxone administration in Pennsylvania. Drug and Alcohol Dependence 238, pages 109555.
Crossref
Justin C. Strickland, Katherine R. Marks, Kirsten E. Smith, Jennifer D. Ellis, J. Gregory Hobelmann & Andrew S. Huhn. (2022) Patient perceptions of higher-dose naloxone nasal spray for opioid overdose. International Journal of Drug Policy 106, pages 103751.
Crossref
Phillip O. Coffin, Sigal Maya & James G. Kahn. (2022) Modeling of overdose and naloxone distribution in the setting of fentanyl compared to heroin. Drug and Alcohol Dependence 236, pages 109478.
Crossref
Kelly Quinn, Sagar Kumar, Calli T. Hunter, Julie O’Donnell & Nicole L. Davis. (2022) Naloxone administration among opioid-involved overdose deaths in 38 United States jurisdictions in the State Unintentional Drug Overdose Reporting System, 2019. Drug and Alcohol Dependence 235, pages 109467.
Crossref
Lucas G. Hill, Claire M. Zagorski & Lindsey J. Loera. (2022) Increasingly powerful opioid antagonists are not necessary. International Journal of Drug Policy 99, pages 103457.
Crossref
Rachel S. Bergstein, Kelly King, G.J. Melendez-Torres & Amanda D. Latimore. (2021) Refusal to accept emergency medical transport following opioid overdose, and conditions that may promote connections to care. International Journal of Drug Policy 97, pages 103296.
Crossref
G. Mohler, S. Mishra, B. Ray, L. Magee, P. Huynh, M. Canada, D. O’Donnell & S. Flaxman. (2021) A modified two-process Knox test for investigating the relationship between law enforcement opioid seizures and overdoses. Proceedings of the Royal Society A: Mathematical, Physical and Engineering Sciences 477:2250.
Crossref
Rosanna Smart, Bryce Pardo & Corey S. Davis. (2020) Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States. Addiction 116:1, pages 6-17.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.